Twiist Postmarket Surveillance Study for Type 1 Diabetes

Part of paid clinical trials in Tampa, Florida.

Sponsor
Deka Research and Development
Study ID
NCT07356089
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • twiist Automated Insulin Delivery System — DEVICE
    twiist(TM) system includes a novel insulin pump, a CGM sensor, and the glycemic-control algorithm

Study Details

The goal of this surveillance study is to collect real-world data on adults and youth with type 1 diabetes (T1D) using twiist(TM) for insulin delivery.

Key Dates

Start date
Dec 9, 2025
Status verified
Jan 2026
Primary completion
May 1, 2027
Completion
May 1, 2028

Study Design

Enrollment
1,875 participants (estimated)

Arms

  • Arm: twiist users

Primary Outcome Measure

Severe hypoglycemia events [ Time Frame: From enrollment to the end of participation at 12 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Jaeb Center for Health ResearchTampaFlorida33647
Research Manager
[email protected]
813-975-8690

Find similar trials in Tampa, FL

By condition
Type 1 diabetes
By specialty
Endocrinology
By research site
Jaeb Center for Health Research· Tampa, FL

Related Studies